NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

If RMAT is under consideration by the FDA, I wonder if the company would prefer to announce that before TLD was announced. Both could clearly be positive, but my thinking is they'd like to have a decision from the FDA before unless it's clear that the FDA is just not acting on things that aren't Covid-19 based.

I believe the company clearly indicated that some dialogue was occurring with the FDA. There might be other things besides RMAT that were being discussed, but it seems like the logical thing. The FDA may have had access to the data before the company did.

We could be in for some very exciting times.

Gary